November 15 2016 LimFlow Receives CE Mark for Purely Percutaneous Critical Limb Ischemia (CLI) Technology Designed to Restore Perfusion for “No Option” Patients View the article.
News THE LIMFLOW SYSTEM FOUND TO BE COST-EFFECTIVE, ACCORDING TO THE NEWEST STUDY PUBLISHED IN THE JOURNAL OF CRITICAL LIMB ISCHEMIA
News PUBLICATION OF ONE YEAR OUTCOMES FROM PROMISE I U.S. STUDY OF THE LIMFLOW SYSTEM DEMONSTRATES EXCELLENT SUSTAINED AMPUTATION-FREE SURVIVAL AND WOUND HEALING IN PATIENTS WITH NO-OPTION CHRONIC LIMB-THREATENING ISCHEMIA
News LIMFLOW RECEIVES JAPAN PMDA APPROVAL FOR CLINICAL STUDY OF MINIMALLY-INVASIVE TECHNOLOGY DESIGNED TO PREVENT AMPUTATIONS IN CHRONIC LIMB-THREATENING ISCHEMIA PATIENTS
